Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2025 08:00 ET | Source: OXB

OXB to participate in upcoming investor conferences and events

OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that...
October 14, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025

ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and...
October 07, 2025 02:40 ET | Source: Cellectis Inc.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
September 16, 2025 08:00 ET | Source: Employ Inc.

Smarter Hiring – with Measurable Results: Employ Showcases AI-Driven Impact at HR Tech 2025

Smarter Hiring – with Measurable Results: Employ Showcases AI-Driven Impact at HR Tech 2025
September 11, 2025 08:30 ET | Source: NANO Nuclear Energy Inc.

NANO Nuclear to be Featured in Upcoming Nuclear Energy Industry Events

New York, N.Y., Sept. 11, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on...
September 09, 2025 07:00 ET | Source: HR Tech

Innovation Takes Center Stage with Scores of New Products Being Launched at HR Tech 2025 Next Week

Innovation Takes Center Stage with Scores of New Products Being Launched at HR Tech 2025 Next Week
September 08, 2025 07:00 ET | Source: WRKdefined

WRKdefined Emerges as Fast-Growing Podcast Network Dedicated to All Things Work

WRKdefined Emerges as Fast-Growing Podcast Network Dedicated to All Things Work
September 01, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences

Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01...
August 28, 2025 08:00 ET | Source: Marker Therapeutics

Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...
August 28, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Participate in Upcoming September Investor Conferences

ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for...